Body weight and composition may theoretically influence distribution volume, but clinical studies have not demonstrated clinically significant differences in elimination based on body mass index or weight alone
One in 6 (17%) of those with a semaglutide/tirzepatide-type prescription also had history of a mental health condition other than alcohol use disorder versus 9% in those without a prescription
Abstract Background In idiopathic intracranial hypertension (IIH), sustained weight loss is the main pillar in modifying disease course, whereby glucagon-like peptide-1 receptor agonists (GLP-1-RAs) could present an attractive treatment option
Rotate injection sites systematically between the abdomen, thigh, and upper arm, clean the site with alcohol and allow it to dry completely before injection, and avoid injecting into areas with existing irritation or scarring
Together, we can help you achieve your health and weight loss goals safely and effectively
